Episode

LCC Advances in ALK+ Cancer in Cantonese

Podcast
Lung Cancer Considered
Published
Aug 14, 2026
Duration seconds
2786
Processing state
not_requested
Canonical source
https://soundcloud.com/lungcancerconsidered/lcc-advances-in-alk-cancer-in
Audio
https://feeds.soundcloud.com/stream/2375065340-lungcancerconsidered-lcc-advances-in-alk-cancer-in.mp3
JSON
/v1/public/podcasts/lung-cancer-considered-246259/episodes/lcc-advances-in-alk-cancer-in-cantonese
Markdown
/podcast/lung-cancer-considered-246259/lcc-advances-in-alk-cancer-in-cantonese.md

Actions

  • POST https://stenobird.com/v1/public/podcasts/lung-cancer-considered-246259/episodes/lcc-advances-in-alk-cancer-in-cantonese/transcription-requests
    Idempotently request low-priority transcript generation for this episode.
  • GET https://stenobird.com/podcast/lung-cancer-considered-246259/lcc-advances-in-alk-cancer-in-cantonese.md
    Read the agent-friendly Markdown representation of this episode resource.

Summary

As part of IASLC’s ongoing series of Lung Cancer Considered podcasts in world languages, Dr. Molly Li moderates a discussion in Cantonese with Dr. Tony Mok, Dr. Chao Zhang, and Dr. Wen-Zhao Zhong. The discussion reviews advances in ALK+ non-small cell lung cancer (NSCLC).